A61K 31/4743
Condensed with ring systems having sulfur as a ring hetero atom
Official title: condensed with ring systems having sulfur as a ring hetero atom
A61K31/4743 (Condensed with ring systems having sulfur as a ring hetero atom) appears on 67 US grants and 130 published applications in this corpus.
Search patents in A61K- Granted patents
- 67
- Published applications
- 130
- Assignees
- 78
- Inventors
- 310
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 1 |
| 2002 | 1 | 4 |
| 2003 | 2 | 6 |
| 2004 | 4 | 9 |
| 2005 | 2 | 10 |
| 2006 | 2 | 16 |
| 2007 | 3 | 9 |
| 2008 | 3 | 8 |
| 2009 | 2 | 6 |
| 2010 | 6 | 10 |
| 2011 | 1 | 5 |
| 2012 | 6 | 2 |
| 2013 | 3 | 4 |
| 2014 | 1 | 4 |
| 2015 | 3 | 3 |
| 2016 | 4 | 4 |
| 2017 | 4 | 5 |
| 2018 | 7 | 7 |
| 2019 | 1 | 2 |
| 2020 | 3 | 3 |
| 2021 | 0 | 0 |
| 2022 | 2 | 2 |
| 2023 | 0 | 2 |
| 2024 | 0 | 4 |
| 2025 | 0 | 4 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cyclic compounds and methods of using same25 Aug 2026US 12,715,876 B2Schrödinger, Inc.
- Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases28 Jun 2022US 11,369,620 B2Zhejiang Dtrm Biopharma Co. Ltd.
- Application of PCSK9 inhibitors in the preparation of drugs for the treatment of inflammatory immune diseases4 Jan 2022US 11,214,625 B2
- Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases24 Mar 2020US 10,596,183 B2Zhejiang Dtrm Biopharma Co. Ltd.
- Use of physiological cooling active ingredients, and agents containing such active ingredients10 Mar 2020US 10,584,134 B2BASF SE
- Heterocyclic compound as taar1 ligand agonist18 Dec 2025US 2025/0382306 A1Shandong Luye Pharmaceutical Co., Ltd.
- Pharmacotherapy for obsessive-compulsive disorder targeting dopamine d1 signal in striatal striosomes4 Dec 2025US 2025/0367212 A1
- Polycyclic compound and use thereof15 May 2025US 2025/0154105 A1Tyk Medicines, Inc.
- Cyclic compounds and their use for the treatment of neurological disorders27 Feb 2025US 2025/0066349 A1Prothena Biosciences Limited
- Prmt5 inhibitors and uses thereof1 Aug 2024US 2024/0254118 A1Gilead Sciences, Inc.
Most cited
By later US patents
- Sulfide and disulfide compounds and compositions for cholesterol management and related uses68US 6,703,422 B2Esperion Therapeutics, Inc. · 2004
- Selective resonance of bodily agents53US 8,195,403 B2The Invention Science Fund I, LLC · 2012
- Method of treating glaucoma34US 6,545,014 B2Texas Biotechnology Corporation · 2003
- Pharmaceutical compositions based on anticholinergics and additional active ingredients23US 7,776,315 B2Boehringer Ingelheim Pharma GMBH & CO.KG · 2010
- Solid dispersions containing kinase inhibitors23US 8,557,995 B2AbbVie Inc. · 2013